期刊文献+

大剂量盐酸氨溴索对ARDS患者呼吸功能的影响 被引量:9

Effect of high dose ambroxol on the pulmonary function of patients with ARDS
下载PDF
导出
摘要 目的:研究大剂量盐酸氨溴索对急性呼吸窘迫综合征(ARDS)患者呼吸功能的影响。方法:选择ARDS患者60例,随机分成小剂量盐酸氨溴索组(A组,n=20),大剂量盐酸氨溴索组(B组,n=20),对照组(C组,n=20)。A组每天给予盐酸氨溴索2mg/kg加0.9%氯化钠溶液500ml静脉滴注,B组每天给予盐酸氨溴索15mg/kg加0.9%氯化钠溶液500ml静脉滴注,C组每天给予0.9%氯化钠溶液500ml静脉滴注,连续使用7d。比较各组患者用药前,用药第3、7天动脉血氧分压(PaO2)、动脉血氧饱和度(SaO2)、氧合指数(PaO2/FiO2)的差异。结果:用药前各组间PaO2、SaO2和PaO2/FiO2无差异。用药第3、7天PaO2、SaO2及PaO2/FiO2,A、B组与C组比较,差异有统计学意义(P<0.05),A组与B组比较,差异有统计学意义(P<0.05)。结论:盐酸氨溴索对ARDS患者呼吸功能有改善作用,且大剂量盐酸氨溴索对ARDS患者呼吸功能的改善作用强于小剂量盐酸氨溴索。 Objective:To investigate the effect of high dose ambroxol on the lung function of patients with acute respiratory distresssyndrome(ARDS).Methods:60 patients with ARDS were enrolled in the study.They were divided randomly into 3 groups.Patients in group A were treated with low dose ambroxol(2 mg/kg)+0.9%NaCl(500 ml),patients in group B received high dose ambroxol(15 mg/kg)+0.9%NaCl(500 ml),others in group C were treated with 0.9%NaCl(500 ml) alone,for 7 consecutive days.The arterial blood samples were taken for blood gas and the parameters of respiratory mechanics were recorded before ambroxol infusion.Outcome of patients in both groups including various pulmonary function indices was analyzed.Results:The blood gas indexes of the patients in group A and group B were better than group C(P0.05),the blood gas indexes of the patients in group B were better than group A(P0.05).Conclusion:Ambroxol can enhance the pulmonary function in patients with ARDS.The effect of high dose ambroxol on the lung function of patients with ARDS is better than low dose.
作者 蔡茜 陈思睿
机构地区 长沙市第三医院
出处 《中国当代医药》 2011年第1期75-76,共2页 China Modern Medicine
关键词 盐酸氨溴索 急性呼吸窘迫综合征 动脉血氧分压 动脉血氧饱和度 Ambroxol Acute respiratory distresssyndrome Arterial partial pressure of oxygen Arterial oxygen saturation
  • 相关文献

参考文献7

二级参考文献16

  • 1慢性支气管炎临床诊断及疗效判定标准[J].中华结核和呼吸疾病杂志,1980,3(1):61-61.
  • 2Park NH, Han ES, Lee CS. The inhibitory effect of ambroxol on respiratory burst, degranulation and cytosolic Ca2+ change in degraded immunoglobulin G-activated neutrophils. Pharmacol Toxicol, 1999, 84:81-87.
  • 3Kimoto A, Saito M, Hirano Y, et al. The effects of YM26818: 1-(2-dimethylaminoethyl)-1-(3,4,5-trimethoxyphenyl) urea and derivatives on pulmonary surfactant secretion and lung compliance. Yakugaku Zasshi,1998,118: 294-300.
  • 4Lee CS, Jang YY, Han ES. Depressant effects of ambroxol on lipopolysaccharide- or fMLP-stimulated free radical production and granule enzyme release by alveolar macrophages. Pulm Pharmacol Ther, 1999,12: 275-84.
  • 5Bernard GR, Artigas A, Brtigham K L, et al. Report of the American European consensus conference on ARDS: definitions, mechanisms,relevant outcomes and clinical trial coordination. Intensive Care Med,1994, 20:225.
  • 6Kupczyk M, Kuna P. Mucolytics in acute and chronic respiratory tract disorders Ⅰ. Pathophysiology and mechanisms of action. Pol Merkuriusz Lek, 2002,12 (69):245-247.
  • 7B. F. Gibbs,W. Schmutzler,I. B. Vollrath,P. Brosthardt,U. Braam,H. H. Wolff,G. Zwadlo-Klarwasser. Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells[J] 1999,Inflammation Research(2):86~93
  • 8A. Gillissen,A. Bartling,S. Schoen,G. Schultze-Werninghaus. Antioxidant Function of Ambroxol in Mononuclear and Polymorphonuclear Cells in Vitro[J] 1997,Lung(4):235~242
  • 9R. R. Wauer,G. Schmalisch,B. B?hme,J. Arand,D. Lehmann. Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome[J] 1992,European Journal of Pediatrics(5):357~363
  • 10Maria Giulia Marini. Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: Double-blind italian multicenter clinical study versus placebo[J] 1991,Lung(1):69~76

共引文献339

同被引文献98

引证文献9

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部